Form 4 for CGTX COGNITION THERAPEUTICS INC
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0001062993-25-001617 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-02-03 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | F - Tax | $0.67 | -29.0K | 262.4K | -10% | -$19.4K | |
| 2025-02-04 | 2025-02-04 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +631.3K | 893.7K | +241% | $0 | |
| I | 2025-02-04 | 2025-01-31 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | P - Purchase | $0.77 | +38.9K | 38.9K | New | +$29.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | F | D | 28,960 | $0.67 | 262,385 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-04 | A | A | 631,300 | $0.00 | 893,685 | D | — | — | |
| 3 | Common | Common Stock | 2025-01-31 | P | A | 38,851 | $0.77 | 38,851 | I By Spouse | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7602 to $0.7816, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |